Immunovant Inc Q4 2022 Earnings Call Transcript - Thomson StreetEvents

Immunovant Inc Q4 2022 Earnings Call Transcript

Immunovant Inc Q4 2022 Earnings Call Transcript - Thomson StreetEvents
Immunovant Inc Q4 2022 Earnings Call Transcript
Published Jun 08, 2022
12 pages (7878 words) — Published Jun 08, 2022
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of IMVT.OQ earnings conference call or presentation 8-Jun-22 12:00pm GMT

  
Brief Excerpt:

...Operator Good morning. My name is Melissa, and I will serve as your conference call operator. (Operator Instructions) As a reminder, this call is being recorded. Joining me on the call today will be Dr. Pete Salzmann, Chief Executive Officer of Immunovant. Before we begin, I would like to remind everyone that today's conference call will include certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, among other things, statements regarding Immunovant's plan to initiate 2 Phase III clinical trials for batoclimab in TED in the second half of calendar year 2022, with an expected top line data readout in the first half of calendar year 2025, and its plan to initiate a Phase III clinical trial in MG by the end of June 2022, with an expected readout in the second half of calendar year 2024. Immunovant's plans to develop batoclimab across a broad range of autoimmune indications, the potential efficacy...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Immunovant Inc
Ticker
IMVT.OQ
Time
12:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Immunovant Inc Initial Phase 1 Results Call Transcript – 2023-09-26 – US$ 54.00 – Edited Transcript of IMVT.OQ conference call or presentation 26-Sep-23 12:00pm GMT

Immunovant Inc Investor Day Transcript – 2022-09-28 – US$ 54.00 – Edited Transcript of IMVT.OQ corporate analyst meeting</ 28-Sep-22 3:15pm GMT

Immunovant Inc To Discuss On Two New Indications For Batoclimab Call Transcript – 2022-09-07 – US$ 54.00 – Edited Transcript of IMVT.OQ conference call or presentation 7-Sep-22 12:00pm GMT

Immunovant Inc at UBS Global Healthcare Conference Transcript – 2022-05-23 – US$ 54.00 – Edited Transcript of IMVT.OQ presentation 23-May-22 5:15pm GMT

Immunovant Inc To Host R&D Day (Virtual) Transcript – 2022-03-30 – US$ 54.00 – Edited Transcript of IMVT.OQ corporate analyst meeting</ 30-Mar-22 1:00pm GMT

Immunovant Inc at JPMorgan Healthcare Conference (Virtual) Transcript – 2022-01-13 – US$ 54.00 – Edited Transcript of IMVT.OQ presentation 13-Jan-22 2:45pm GMT

Immunovant Inc To Discuss Initiation of Phase 3 Trial for Batoclimab in Myasthenia Gravis in the First Half of 2022 Call Transcript – 2022-01-05 – US$ 54.00 – Edited Transcript of IMVT.OQ conference call or presentation 5-Jan-22 1:00pm GMT

Immunovant Inc at Stifel Healthcare Conference (Virtual) Transcript – 2021-11-17 – US$ 54.00 – Edited Transcript of IMVT.OQ presentation 17-Nov-21 7:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Immunovant Inc Q4 2022 Earnings Call Transcript" Jun 08, 2022. Alacra Store. May 18, 2024. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q4-2022-Immunovant-Inc-Earnings-Call-T15242518>
  
APA:
Thomson StreetEvents. (2022). Immunovant Inc Q4 2022 Earnings Call Transcript Jun 08, 2022. New York, NY: Alacra Store. Retrieved May 18, 2024 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q4-2022-Immunovant-Inc-Earnings-Call-T15242518>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.